Opportunities for developing neural stem cell treatments for acute ischemic stroke: A systematic review and gap analysis

•3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell administration within 24 h.•Stem cell therapy appears to be associated with beneficial effects post stroke.•A gap analysis identified numerou...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical neuroscience Vol. 120; pp. 64 - 75
Main Authors Buchlak, Quinlan D, Esmaili, Nazanin, Moore, Justin
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.02.2024
Subjects
Online AccessGet full text
ISSN0967-5868
1532-2653
1532-2653
DOI10.1016/j.jocn.2023.12.021

Cover

Abstract •3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell administration within 24 h.•Stem cell therapy appears to be associated with beneficial effects post stroke.•A gap analysis identified numerous opportunities for treatment development. Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development.
AbstractList Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development.
•3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell administration within 24 h.•Stem cell therapy appears to be associated with beneficial effects post stroke.•A gap analysis identified numerous opportunities for treatment development. Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development.
Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development.Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development.
Author Moore, Justin
Esmaili, Nazanin
Buchlak, Quinlan D
Author_xml – sequence: 1
  givenname: Quinlan D
  orcidid: 0000-0001-6749-3223
  surname: Buchlak
  fullname: Buchlak, Quinlan D
  email: quinlan.buchlak1@my.nd.edu.au
  organization: Department of Neurosurgery, Monash Health, Melbourne, VIC, Australia
– sequence: 2
  givenname: Nazanin
  surname: Esmaili
  fullname: Esmaili, Nazanin
  organization: School of Medicine, University of Notre Dame Australia, Sydney, NSW, Australia
– sequence: 3
  givenname: Justin
  surname: Moore
  fullname: Moore, Justin
  organization: Department of Neurosurgery, Monash Health, Melbourne, VIC, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38199150$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1v1DAQhi1URLeFP8AB-cglwR9xEldcqgpapEq9tGfLccbF28QOtlPYf4-XLRx6KKeRRs8zmpn3BB354AGh95TUlND207beBuNrRhivKasJo6_QhgrOKtYKfoQ2RLZdJfq2P0YnKW0JIbLh5A065j2VkgqyQb9uliXEvHqXHSRsQ8QjPMIUFufvsYc16gmnDDM2ME04R9B5Bp8PqDZrBuyS-Q6zM4WL4QHO8DlOu72jc2lGeHTwE2s_4nu9lKqnXXLpLXpt9ZTg3VM9RXdfv9xeXFXXN5ffLs6vK8NFnysj2qazQwdjLynrCW9sJyxjo6Vm0JZIazQDYbtOgG6azjDSD6RjZKAwMkb5Kfp4mLvE8GOFlNVc9i23aA9hTYpJyptG9kQW9MMTug4zjGqJbtZxp_5-qwDsAJgYUopg_yGUqH0kaqv2kah9JIoyRf4s8PkgQbmyvCKqZBx4A6OLYLIag3tZP3umm8l5Z_T0ALv_yb8B51mpwg
Cites_doi 10.1016/j.expneurol.2020.113275
10.1016/j.jcyt.2021.03.005
10.1161/STROKEAHA.117.018288
10.1161/CIR.0000000000001052
10.1016/j.jcyt.2018.04.004
10.1136/bmj.d5928
10.2174/187153012800493477
10.1016/j.scr.2011.07.001
10.1016/j.jcyt.2015.04.007
10.1016/j.jstrokecerebrovasdis.2022.106940
10.1016/j.acthis.2014.05.002
10.1016/j.bbr.2013.10.030
10.1016/S0140-6736(16)30513-X
10.1016/S1474-4422(17)30046-7
10.1016/j.bbr.2013.05.011
10.1016/j.bbi.2014.12.015
10.1016/j.phrs.2022.106332
10.1016/S1474-4422(17)30299-5
10.1055/s-0038-1649503
10.4103/1673-5374.177739
10.3390/ijms21207795
10.1016/j.jstrokecerebrovasdis.2018.05.001
10.1186/scrt224
10.1016/S1474-4422(22)00526-9
10.1186/s13643-021-01626-4
10.1161/STROKEAHA.119.025436
10.1016/j.expneurol.2020.113531
10.1038/jcbfm.2010.213
10.3174/ajnr.A5586
10.1186/1471-2288-14-43
10.1016/j.brainres.2013.05.024
10.3727/096368912X657251
10.1073/pnas.1103113108
10.1016/j.trsl.2016.04.003
10.1016/j.mvr.2019.01.001
10.18632/oncotarget.22155
10.1016/j.lfs.2013.12.016
10.1016/j.biopha.2018.09.084
10.1016/j.redox.2021.102197
10.1016/j.jcyt.2014.12.004
10.1016/j.ijcard.2015.03.137
10.5966/sctm.2013-0178
10.1159/000086518
10.1016/j.jstrokecerebrovasdis.2022.106453
10.3389/fnagi.2020.575990
10.1056/NEJMoa0804656
10.1016/S0092-8674(01)00409-3
10.1038/cddis.2014.359
10.1186/scrt544
10.1016/j.pneurobio.2018.05.004
10.1038/ncomms10523
10.1523/JNEUROSCI.1643-16.2016
10.1089/scd.2008.0253
10.1016/j.brainres.2017.12.017
10.3390/ijms22147703
10.26599/JNR.2018.9040002
10.1073/pnas.1121003109
10.3760/cma.j.issn.0366-6999.20122965
10.1212/WNL.0000000000011440
10.1172/jci.insight.126268
10.1016/j.jcyt.2019.04.055
10.1161/STROKEAHA.113.003379
10.5966/sctm.2014-0184
10.1016/j.jocn.2019.08.051
10.1006/exnr.2001.7853
10.1186/scrt519
10.1016/j.bbr.2015.07.048
10.1161/STROKEAHA.109.575993
ContentType Journal Article
Copyright 2023 Elsevier Ltd
Copyright © 2023 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2023 Elsevier Ltd
– notice: Copyright © 2023 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jocn.2023.12.021
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-2653
EndPage 75
ExternalDocumentID 38199150
10_1016_j_jocn_2023_12_021
S0967586823004009
Genre Systematic Review
Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABJNI
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSN
SSZ
T5K
UHS
WUQ
Z5R
~G-
AFCTW
AGRNS
RIG
AAYXX
CITATION
EFLBG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACLOT
~HD
ID FETCH-LOGICAL-c358t-c5647fb7ed89128034f75f22df1cbaf09fca2e5f775ea447c208b0720b1ed2213
IEDL.DBID .~1
ISSN 0967-5868
1532-2653
IngestDate Sat Sep 27 17:15:41 EDT 2025
Sun Jul 13 01:32:46 EDT 2025
Wed Sep 10 04:22:26 EDT 2025
Sat Jul 05 17:13:11 EDT 2025
Tue Aug 26 16:31:17 EDT 2025
IsPeerReviewed true
IsScholarly true
Language English
License Copyright © 2023 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c358t-c5647fb7ed89128034f75f22df1cbaf09fca2e5f775ea447c208b0720b1ed2213
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
ObjectType-Review-4
content type line 23
ORCID 0000-0001-6749-3223
PMID 38199150
PQID 2913449809
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_2913449809
pubmed_primary_38199150
crossref_primary_10_1016_j_jocn_2023_12_021
elsevier_sciencedirect_doi_10_1016_j_jocn_2023_12_021
elsevier_clinicalkey_doi_10_1016_j_jocn_2023_12_021
PublicationCentury 2000
PublicationDate February 2024
2024-02-00
2024-Feb
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: February 2024
PublicationDecade 2020
PublicationPlace Scotland
PublicationPlace_xml – name: Scotland
PublicationTitle Journal of clinical neuroscience
PublicationTitleAlternate J Clin Neurosci
PublicationYear 2024
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Zhang, Xie, Xiong, Liu, Hu, Cao (b0140) 2018; 1680
Katan, Luft (b0015) 2018; 38
Du, Liu, Dang, Zhu, Su, Fan (b0120) 2014; 116
Dabrowska, Andrzejewska, Kozlowska, Strzemecki, Janowski, Lukomska (b0025) 2021; 336
Oh, Choi, Chang, Shin, Lee, Jeon (b0235) 2015; 17
Ramos, Vasconcelos-Dos-Santos, Lopes de Souza, Rosado-de-Castro, Barbosa da Fonseca, Gutfilen (b0275) 2013; 1522
Li, Mao, Zhang, Wan, Jing, Hua (b0220) 2016; 301
Mäkelä, Takalo, Arvola, Haapanen, Yannopoulos, Blanco (b0325) 2015; 17
Zhao, Duan, Reyes, Keene, Verfaillie, Low (b0345) 2002; 174
Ryu, Lee, Kim, Yoon (b0225) 2016; 11
Blau, Brazelton, Weimann (b0070) 2001; 105
Fischer, Harting, Jimenez, Monzon-Posadas, Xue, Savitz (b0135) 2009; 18
Kamiya, Ueda, Nito, Kamiya, Inaba, Suda (b0260) 2014; 95
Jiang, Wang, Yu, Ou, Liu, Zhao (b0270) 2013; 250
Gómez-Pinedo, Sanchez-Rojas, Benito-Martin, Lendinez, León-Espinosa, Rascón (b0085) 2018; 27
Guzman, Janowski, Walczak (b0315) 2018; 49
Nito, Sowa, Nakajima, Sakamoto, Suda, Nishiyama (b0090) 2018; 108
Hooijmans, Rovers, de Vries, Leenaars, Ritskes-Hoitinga, Langendam (b0160) 2014; 14
Boltze, Modo, Mays, Taguchi, Jolkkonen, Savitz (b0310) 2019; 50
He, Sussman, Steinberg (b0080) 2020; 12
Savitz, Dinsmore, Wu, Henderson, Stieg, Caplan (b0125) 2005; 20
[Internet]. 2020;5. Available from: http://dx.doi.org/10.1172/jci.insight.126268.
Kasahara, Yamahara, Soma, Stern, Nakagomi, Matsuyama (b0215) 2016; 176
Patkar, Tate, Modo, Plevin, Carswell (b0065) 2012; 8
Chen, Tsai, Wallace, Chen, Huang, Sung (b0230) 2015; 201
Bacigaluppi, Russo, Peruzzotti-Jametti, Rossi, Sandrone, Butti (b0075) 2016; 36
Tsao, Aday, Almarzooq, Alonso, Beaton, Bittencourt (b0010) 2022; 145
Bhatia, Gupta, Khurana, Sharma, Khandelwal (b0145) 2018; 39
Banerjee, Bentley, Hamady, Marley, Davis, Shlebak (b0245) 2014; 3
Huang, Wong, Snyder, Hamblin, Lee (b0255) 2014; 5
Cui, Kerkelä, Bakreen, Nitzsche, Andrzejewska, Nowakowski (b0320) 2015; 6
Feigin, Abajobir, Abate, Abd-Allah, Abdulle, Abera (b0005) 2017; 16
Doeppner, Kaltwasser, Teli, Bretschneider, Bähr, Hermann (b0250) 2014; 5
Kalladka, Sinden, Pollock, Haig, McLean, Smith (b0300) 2016; 388
Lujan, Chanda, Ahlenius, Südhof, Wernig (b0340) 2012; 109
Ergul, Kelly-Cobbs, Abdalla, Fagan (b0050) 2012; 12
Chua, Pendharkar, Wang, Choi, Andres, Gaeta (b0330) 2011; 31
Hacke, Kaste, Bluhmki, Brozman, Dávalos, Guidetti (b0055) 2008; 359
Choi, Kim, Shon, Park, Kim, Kang (b0305) 2018; 20
Hess, Wechsler, Clark, Savitz, Ford, Chiu (b0205) 2017; 16
Kim, Efe, Zhu, Talantova, Yuan, Wang (b0335) 2011; 108
Yuan, Liao, Feng, Lou, Niu, Zhang (b0285) 2013; 4
Zhang, Zhu, Hu, Xiang, Deng, Wu (b0210) 2017; 8
Yuan, Wen, Yang, Pang, Gao, Liu (b0280) 2013; 126
Kim, Lee, Kim, Park, Kang, Lee (b0045) 2023; 32
Yang, Lavayen, Liu, Sanz, DeMars, Larochelle (b0030) 2021; 48
Moniche, Cabezas-Rodriguez, Valverde, Escudero-Martinez, Lebrato-Hernandez, Pardo-Galiana (b0165) 2023; 22
Wang, Liu, Lu, Jiang, Cui, Yu (b0240) 2015; 45
Mitkari, Nitzsche, Kerkelä, Kuptsova, Huttunen, Nystedt (b0265) 2014; 259
Eckert, Huang, Gonzalez, Kim, Hamblin, Lee (b0095) 2015; 4
Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury.
Liu, Guo, Zhou, Pan, Yan (b0195) 2019; 123
Wei, Yu, Gu, Taylor, Song, Liu (b0110) 2013; 22
Chung, Chang, Bang, Moon, Kim, Kim (b0170) 2021; 96
Yuan, Rosenberg, Liu, Grant, Ma (b0200) 2019; 21
Mao, Wang, Guo, Liu, Zheng, Chen (b0105) 2018; 6
Boese, Eckert, Hamblin, Lee (b0035) 2020; 329
Yang, Gao, Yang, Zhang, Chen, Yang (b0295) 2022; 182
Hamblin, Lee (b0020) 2021; 22
Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow (b0150) 2021; 10
Lam, Wang, Chin, Tong, Wang, Lo (b0185) 2020; 71
Higgins, Altman, Gøtzsche, Jüni, Moher, Oxman (b0155) 2011; 343
Wang, Sun, Sun, Gong, Liu, Wang (b0290) 2022; 31
[Internet]. 2018;Available from: http://dx.doi.org/10.1016/j.pneurobio.2018.05.004.
Pendharkar, Chua, Andres, Wang, Gaeta, Wang (b0130) 2010; 41
Sharma, Sane, Gokulchandran, Khopkar, Paranjape, Sundaram (b0115) 2014; 2014
Law, Tan, Chin, Wong, Wan Yahya, Muda (b0175) 2021; 23
Korshunova I, Rhein S, García-González D, Stölting I, Pfisterer U, Barta A, Dmytriyeva O, Kirkeby A, Schwaninger M, Khodosevich K. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells.
Lee, Kim, Lee, Jung, Oh, Kim (b0190) 2020; 21
Shi, Zhang, Pu, Mao, Hu, Jiang (b0040) 2016; 7
Savitz SI, Cramer SC, Wechsler L, STEPS 3 Consortium (b0060) 2014; 45
Ergul (10.1016/j.jocn.2023.12.021_b0050) 2012; 12
Du (10.1016/j.jocn.2023.12.021_b0120) 2014; 116
Kim (10.1016/j.jocn.2023.12.021_b0335) 2011; 108
Ryu (10.1016/j.jocn.2023.12.021_b0225) 2016; 11
Choi (10.1016/j.jocn.2023.12.021_b0305) 2018; 20
Bacigaluppi (10.1016/j.jocn.2023.12.021_b0075) 2016; 36
Chung (10.1016/j.jocn.2023.12.021_b0170) 2021; 96
Lee (10.1016/j.jocn.2023.12.021_b0190) 2020; 21
Boese (10.1016/j.jocn.2023.12.021_b0035) 2020; 329
Mitkari (10.1016/j.jocn.2023.12.021_b0265) 2014; 259
Guzman (10.1016/j.jocn.2023.12.021_b0315) 2018; 49
Wei (10.1016/j.jocn.2023.12.021_b0110) 2013; 22
Wang (10.1016/j.jocn.2023.12.021_b0240) 2015; 45
Jiang (10.1016/j.jocn.2023.12.021_b0270) 2013; 250
Hess (10.1016/j.jocn.2023.12.021_b0205) 2017; 16
Shi (10.1016/j.jocn.2023.12.021_b0040) 2016; 7
Savitz SI, Cramer SC, Wechsler L, STEPS 3 Consortium (10.1016/j.jocn.2023.12.021_b0060) 2014; 45
Law (10.1016/j.jocn.2023.12.021_b0175) 2021; 23
Patkar (10.1016/j.jocn.2023.12.021_b0065) 2012; 8
Kamiya (10.1016/j.jocn.2023.12.021_b0260) 2014; 95
Feigin (10.1016/j.jocn.2023.12.021_b0005) 2017; 16
10.1016/j.jocn.2023.12.021_b0100
Hacke (10.1016/j.jocn.2023.12.021_b0055) 2008; 359
Lam (10.1016/j.jocn.2023.12.021_b0185) 2020; 71
Yang (10.1016/j.jocn.2023.12.021_b0295) 2022; 182
Savitz (10.1016/j.jocn.2023.12.021_b0125) 2005; 20
Sharma (10.1016/j.jocn.2023.12.021_b0115) 2014; 2014
Oh (10.1016/j.jocn.2023.12.021_b0235) 2015; 17
Yuan (10.1016/j.jocn.2023.12.021_b0280) 2013; 126
Tsao (10.1016/j.jocn.2023.12.021_b0010) 2022; 145
Higgins (10.1016/j.jocn.2023.12.021_b0155) 2011; 343
Mäkelä (10.1016/j.jocn.2023.12.021_b0325) 2015; 17
Nito (10.1016/j.jocn.2023.12.021_b0090) 2018; 108
Bhatia (10.1016/j.jocn.2023.12.021_b0145) 2018; 39
Doeppner (10.1016/j.jocn.2023.12.021_b0250) 2014; 5
Zhang (10.1016/j.jocn.2023.12.021_b0210) 2017; 8
Chen (10.1016/j.jocn.2023.12.021_b0230) 2015; 201
10.1016/j.jocn.2023.12.021_b0180
Boltze (10.1016/j.jocn.2023.12.021_b0310) 2019; 50
Dabrowska (10.1016/j.jocn.2023.12.021_b0025) 2021; 336
Mao (10.1016/j.jocn.2023.12.021_b0105) 2018; 6
Pendharkar (10.1016/j.jocn.2023.12.021_b0130) 2010; 41
Yuan (10.1016/j.jocn.2023.12.021_b0200) 2019; 21
Zhao (10.1016/j.jocn.2023.12.021_b0345) 2002; 174
Huang (10.1016/j.jocn.2023.12.021_b0255) 2014; 5
Eckert (10.1016/j.jocn.2023.12.021_b0095) 2015; 4
Liu (10.1016/j.jocn.2023.12.021_b0195) 2019; 123
Kim (10.1016/j.jocn.2023.12.021_b0045) 2023; 32
Li (10.1016/j.jocn.2023.12.021_b0220) 2016; 301
Yuan (10.1016/j.jocn.2023.12.021_b0285) 2013; 4
Katan (10.1016/j.jocn.2023.12.021_b0015) 2018; 38
He (10.1016/j.jocn.2023.12.021_b0080) 2020; 12
Blau (10.1016/j.jocn.2023.12.021_b0070) 2001; 105
Chua (10.1016/j.jocn.2023.12.021_b0330) 2011; 31
Zhang (10.1016/j.jocn.2023.12.021_b0140) 2018; 1680
Page (10.1016/j.jocn.2023.12.021_b0150) 2021; 10
Kalladka (10.1016/j.jocn.2023.12.021_b0300) 2016; 388
Ramos (10.1016/j.jocn.2023.12.021_b0275) 2013; 1522
Hamblin (10.1016/j.jocn.2023.12.021_b0020) 2021; 22
Fischer (10.1016/j.jocn.2023.12.021_b0135) 2009; 18
Hooijmans (10.1016/j.jocn.2023.12.021_b0160) 2014; 14
Lujan (10.1016/j.jocn.2023.12.021_b0340) 2012; 109
Cui (10.1016/j.jocn.2023.12.021_b0320) 2015; 6
Banerjee (10.1016/j.jocn.2023.12.021_b0245) 2014; 3
Gómez-Pinedo (10.1016/j.jocn.2023.12.021_b0085) 2018; 27
Yang (10.1016/j.jocn.2023.12.021_b0030) 2021; 48
Moniche (10.1016/j.jocn.2023.12.021_b0165) 2023; 22
Kasahara (10.1016/j.jocn.2023.12.021_b0215) 2016; 176
Wang (10.1016/j.jocn.2023.12.021_b0290) 2022; 31
References_xml – volume: 116
  start-page: 1075
  year: 2014
  end-page: 1084
  ident: b0120
  article-title: Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats
  publication-title: Acta Histochem
– volume: 17
  start-page: 1090
  year: 2015
  end-page: 1103
  ident: b0235
  article-title: Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells
  publication-title: Cytotherapy
– volume: 8
  start-page: 14
  year: 2012
  end-page: 25
  ident: b0065
  article-title: Conditionally immortalised neural stem cells promote functional recovery and brain plasticity after transient focal cerebral ischaemia in mice
  publication-title: Stem Cell Res
– volume: 388
  start-page: 787
  year: 2016
  end-page: 796
  ident: b0300
  article-title: Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study
  publication-title: Lancet
– volume: 41
  start-page: 2064
  year: 2010
  end-page: 2070
  ident: b0130
  article-title: Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia
  publication-title: Stroke
– reference: [Internet]. 2020;5. Available from: http://dx.doi.org/10.1172/jci.insight.126268.
– volume: 22
  start-page: 977
  year: 2013
  end-page: 991
  ident: b0110
  article-title: Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice
  publication-title: Cell Transplant
– volume: 6
  start-page: 11
  year: 2015
  ident: b0320
  article-title: The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity
  publication-title: Stem Cell Res Ther
– volume: 145
  start-page: e153
  year: 2022
  end-page: e639
  ident: b0010
  article-title: Heart disease and stroke statistics-2022 update: A report from the American Heart Association
  publication-title: Circulation
– volume: 6
  start-page: 74
  year: 2018
  end-page: 80
  ident: b0105
  article-title: Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study
  publication-title: J Neurorestoratology
– volume: 71
  start-page: 226
  year: 2020
  end-page: 233
  ident: b0185
  article-title: Topically applied adipose-derived mesenchymal stem cell treatment in experimental focal cerebral ischemia
  publication-title: J Clin Neurosci
– volume: 8
  start-page: 102067
  year: 2017
  end-page: 102077
  ident: b0210
  article-title: Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke
  publication-title: Oncotarget
– reference: Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury.
– volume: 2014
  year: 2014
  ident: b0115
  article-title: Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke
  publication-title: Stroke Res Treat
– volume: 174
  start-page: 11
  year: 2002
  end-page: 20
  ident: b0345
  article-title: Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats
  publication-title: Exp Neurol
– volume: 22
  start-page: 137
  year: 2023
  end-page: 146
  ident: b0165
  article-title: Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial
  publication-title: Lancet Neurol
– volume: 20
  start-page: 820
  year: 2018
  end-page: 829
  ident: b0305
  article-title: The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model
  publication-title: Cytotherapy
– volume: 109
  start-page: 2527
  year: 2012
  end-page: 2532
  ident: b0340
  article-title: Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells
  publication-title: Proc Natl Acad Sci U S A
– volume: 96
  start-page: e1012
  year: 2021
  end-page: e1023
  ident: b0170
  article-title: STARTING-2 Collaborators. Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke
  publication-title: Neurology
– volume: 18
  start-page: 683
  year: 2009
  end-page: 692
  ident: b0135
  article-title: Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect
  publication-title: Stem Cells Dev
– volume: 23
  start-page: 833
  year: 2021
  end-page: 840
  ident: b0175
  article-title: The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy
  publication-title: Cytotherapy
– volume: 31
  year: 2022
  ident: b0290
  article-title: Dental pulp stem cell therapy in ischemic stroke: A meta-analysis of preclinical studies
  publication-title: J Stroke Cerebrovasc Dis
– volume: 14
  start-page: 43
  year: 2014
  ident: b0160
  article-title: SYRCLE’s risk of bias tool for animal studies
  publication-title: BMC Med Res Methodol
– volume: 336
  year: 2021
  ident: b0025
  article-title: Neuroinflammation evoked by brain injury in a rat model of lacunar infarct
  publication-title: Exp Neurol
– volume: 45
  start-page: 98
  year: 2015
  end-page: 108
  ident: b0240
  article-title: CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice
  publication-title: Brain Behav Immun
– volume: 5
  start-page: 129
  year: 2014
  ident: b0255
  article-title: Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury
  publication-title: Stem Cell Res Ther
– volume: 4
  start-page: 841
  year: 2015
  end-page: 851
  ident: b0095
  article-title: Bystander effect fuels human induced pluripotent stem cell-derived neural stem cells to quickly attenuate early stage neurological deficits after stroke
  publication-title: Stem Cells Transl Med
– volume: 7
  start-page: 10523
  year: 2016
  ident: b0040
  article-title: Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury
  publication-title: Nat Commun
– volume: 38
  start-page: 208
  year: 2018
  end-page: 211
  ident: b0015
  article-title: Global burden of stroke
  publication-title: Semin Neurol
– volume: 48
  year: 2021
  ident: b0030
  article-title: Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism
  publication-title: Redox Biol
– volume: 12
  start-page: 148
  year: 2012
  end-page: 158
  ident: b0050
  article-title: Cerebrovascular complications of diabetes: focus on stroke
  publication-title: Endocr Metab Immune Disord Drug Targets
– volume: 1522
  start-page: 1
  year: 2013
  end-page: 11
  ident: b0275
  article-title: Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats
  publication-title: Brain Res
– volume: 105
  start-page: 829
  year: 2001
  end-page: 841
  ident: b0070
  article-title: The evolving concept of a stem cell: entity or function?
  publication-title: Cell
– volume: 108
  start-page: 1005
  year: 2018
  end-page: 1014
  ident: b0090
  article-title: Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia
  publication-title: Biomed Pharmacother
– volume: 16
  start-page: 360
  year: 2017
  end-page: 368
  ident: b0205
  article-title: Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
  publication-title: Lancet Neurol
– reference: Korshunova I, Rhein S, García-González D, Stölting I, Pfisterer U, Barta A, Dmytriyeva O, Kirkeby A, Schwaninger M, Khodosevich K. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells.
– volume: 20
  start-page: 101
  year: 2005
  end-page: 107
  ident: b0125
  article-title: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study
  publication-title: Cerebrovasc Dis
– volume: 17
  start-page: 392
  year: 2015
  end-page: 402
  ident: b0325
  article-title: Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model
  publication-title: Cytotherapy
– volume: 176
  start-page: 69
  year: 2016
  end-page: 80
  ident: b0215
  article-title: Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model
  publication-title: Transl Res
– volume: 10
  start-page: 89
  year: 2021
  ident: b0150
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: Syst Rev
– volume: 4
  start-page: 73
  year: 2013
  ident: b0285
  article-title: Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion
  publication-title: Stem Cell Res Ther
– volume: 32
  year: 2023
  ident: b0045
  article-title: Frequency, management, and outcomes of early neurologic deterioration due to stroke progression or recurrence
  publication-title: J Stroke Cerebrovasc Dis
– volume: 36
  start-page: 10529
  year: 2016
  end-page: 10544
  ident: b0075
  article-title: Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes
  publication-title: J Neurosci
– volume: 259
  start-page: 50
  year: 2014
  end-page: 59
  ident: b0265
  article-title: Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery
  publication-title: Behav Brain Res
– volume: 250
  start-page: 222
  year: 2013
  end-page: 229
  ident: b0270
  article-title: Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia
  publication-title: Behav Brain Res
– volume: 22
  start-page: 7703
  year: 2021
  ident: b0020
  article-title: Neural stem cells for early ischemic stroke
  publication-title: Int J Mol Sci
– volume: 201
  start-page: 668
  year: 2015
  end-page: 683
  ident: b0230
  article-title: Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats
  publication-title: Int J Cardiol
– volume: 45
  start-page: 634
  year: 2014
  end-page: 639
  ident: b0060
  article-title: Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials
  publication-title: Stroke
– volume: 1680
  start-page: 143
  year: 2018
  end-page: 154
  ident: b0140
  article-title: Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats
  publication-title: Brain Res
– volume: 123
  start-page: 74
  year: 2019
  end-page: 80
  ident: b0195
  article-title: Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke
  publication-title: Microvasc Res
– volume: 49
  start-page: 1075
  year: 2018
  end-page: 1082
  ident: b0315
  article-title: Intra-arterial delivery of cell therapies for stroke
  publication-title: Stroke
– volume: 329
  year: 2020
  ident: b0035
  article-title: Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains
  publication-title: Exp Neurol
– volume: 182
  year: 2022
  ident: b0295
  article-title: Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis
  publication-title: Pharmacol Res
– volume: 3
  start-page: 1322
  year: 2014
  end-page: 1330
  ident: b0245
  article-title: Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke
  publication-title: Stem Cells Transl Med
– volume: 359
  start-page: 1317
  year: 2008
  end-page: 1329
  ident: b0055
  article-title: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
  publication-title: N Engl J Med
– reference: [Internet]. 2018;Available from: http://dx.doi.org/10.1016/j.pneurobio.2018.05.004.
– volume: 21
  start-page: 7795
  year: 2020
  ident: b0190
  article-title: Enhancing the therapeutic potential of CCL2-overexpressing mesenchymal stem cells in acute stroke
  publication-title: Int J Mol Sci
– volume: 5
  start-page: e1386
  year: 2014
  ident: b0250
  article-title: Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice
  publication-title: Cell Death Dis
– volume: 343
  year: 2011
  ident: b0155
  article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
  publication-title: BMJ
– volume: 50
  start-page: 3299
  year: 2019
  end-page: 3306
  ident: b0310
  article-title: Stem cells as an emerging paradigm in stroke 4
  publication-title: Stroke
– volume: 31
  start-page: 1263
  year: 2011
  end-page: 1271
  ident: b0330
  article-title: Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes
  publication-title: J Cereb Blood Flow Metab
– volume: 12
  year: 2020
  ident: b0080
  article-title: Revisiting stem cell-based clinical trials for ischemic stroke
  publication-title: Front Aging Neurosci
– volume: 11
  start-page: 298
  year: 2016
  end-page: 304
  ident: b0225
  article-title: Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain
  publication-title: Neural Regen Res
– volume: 27
  start-page: 2453
  year: 2018
  end-page: 2465
  ident: b0085
  article-title: Evaluation of the safety and efficacy of the therapeutic potential of adipose-derived stem cells injected in the cerebral ischemic penumbra
  publication-title: J Stroke Cerebrovasc Dis
– volume: 95
  start-page: 22
  year: 2014
  end-page: 28
  ident: b0260
  article-title: Effect of repeated allogeneic bone marrow mononuclear cell transplantation on brain injury following transient focal cerebral ischemia in rats
  publication-title: Life Sci
– volume: 301
  start-page: 287
  year: 2016
  end-page: 292
  ident: b0220
  article-title: Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke
  publication-title: Behav Brain Res
– volume: 39
  start-page: 899
  year: 2018
  end-page: 904
  ident: b0145
  article-title: Randomized assessment of the safety and efficacy of intra-arterial infusion of autologous stem cells in subacute ischemic stroke
  publication-title: AJNR Am J Neuroradiol
– volume: 126
  start-page: 1302
  year: 2013
  end-page: 1309
  ident: b0280
  article-title: Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke
  publication-title: Chin Med J (Engl)
– volume: 16
  start-page: 877
  year: 2017
  end-page: 897
  ident: b0005
  article-title: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  publication-title: Lancet Neurol
– volume: 108
  start-page: 7838
  year: 2011
  end-page: 7843
  ident: b0335
  article-title: Direct reprogramming of mouse fibroblasts to neural progenitors
  publication-title: Proc Natl Acad Sci U S A
– volume: 21
  start-page: 1033
  year: 2019
  end-page: 1048
  ident: b0200
  article-title: Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment
  publication-title: Cytotherapy
– volume: 329
  year: 2020
  ident: 10.1016/j.jocn.2023.12.021_b0035
  article-title: Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2020.113275
– volume: 23
  start-page: 833
  year: 2021
  ident: 10.1016/j.jocn.2023.12.021_b0175
  article-title: The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2021.03.005
– volume: 49
  start-page: 1075
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0315
  article-title: Intra-arterial delivery of cell therapies for stroke
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.117.018288
– volume: 145
  start-page: e153
  year: 2022
  ident: 10.1016/j.jocn.2023.12.021_b0010
  article-title: Heart disease and stroke statistics-2022 update: A report from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000001052
– volume: 20
  start-page: 820
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0305
  article-title: The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2018.04.004
– volume: 343
  year: 2011
  ident: 10.1016/j.jocn.2023.12.021_b0155
  article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
  publication-title: BMJ
  doi: 10.1136/bmj.d5928
– volume: 12
  start-page: 148
  year: 2012
  ident: 10.1016/j.jocn.2023.12.021_b0050
  article-title: Cerebrovascular complications of diabetes: focus on stroke
  publication-title: Endocr Metab Immune Disord Drug Targets
  doi: 10.2174/187153012800493477
– volume: 8
  start-page: 14
  year: 2012
  ident: 10.1016/j.jocn.2023.12.021_b0065
  article-title: Conditionally immortalised neural stem cells promote functional recovery and brain plasticity after transient focal cerebral ischaemia in mice
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2011.07.001
– volume: 17
  start-page: 1090
  year: 2015
  ident: 10.1016/j.jocn.2023.12.021_b0235
  article-title: Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2015.04.007
– volume: 32
  year: 2023
  ident: 10.1016/j.jocn.2023.12.021_b0045
  article-title: Frequency, management, and outcomes of early neurologic deterioration due to stroke progression or recurrence
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2022.106940
– volume: 116
  start-page: 1075
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0120
  article-title: Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats
  publication-title: Acta Histochem
  doi: 10.1016/j.acthis.2014.05.002
– volume: 259
  start-page: 50
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0265
  article-title: Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2013.10.030
– volume: 388
  start-page: 787
  year: 2016
  ident: 10.1016/j.jocn.2023.12.021_b0300
  article-title: Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30513-X
– volume: 16
  start-page: 360
  year: 2017
  ident: 10.1016/j.jocn.2023.12.021_b0205
  article-title: Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(17)30046-7
– volume: 250
  start-page: 222
  year: 2013
  ident: 10.1016/j.jocn.2023.12.021_b0270
  article-title: Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2013.05.011
– volume: 45
  start-page: 98
  year: 2015
  ident: 10.1016/j.jocn.2023.12.021_b0240
  article-title: CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2014.12.015
– volume: 182
  year: 2022
  ident: 10.1016/j.jocn.2023.12.021_b0295
  article-title: Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2022.106332
– volume: 16
  start-page: 877
  year: 2017
  ident: 10.1016/j.jocn.2023.12.021_b0005
  article-title: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(17)30299-5
– volume: 38
  start-page: 208
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0015
  article-title: Global burden of stroke
  publication-title: Semin Neurol
  doi: 10.1055/s-0038-1649503
– volume: 11
  start-page: 298
  year: 2016
  ident: 10.1016/j.jocn.2023.12.021_b0225
  article-title: Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.177739
– volume: 2014
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0115
  article-title: Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke
  publication-title: Stroke Res Treat
– volume: 21
  start-page: 7795
  year: 2020
  ident: 10.1016/j.jocn.2023.12.021_b0190
  article-title: Enhancing the therapeutic potential of CCL2-overexpressing mesenchymal stem cells in acute stroke
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21207795
– volume: 27
  start-page: 2453
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0085
  article-title: Evaluation of the safety and efficacy of the therapeutic potential of adipose-derived stem cells injected in the cerebral ischemic penumbra
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2018.05.001
– volume: 4
  start-page: 73
  year: 2013
  ident: 10.1016/j.jocn.2023.12.021_b0285
  article-title: Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt224
– volume: 22
  start-page: 137
  year: 2023
  ident: 10.1016/j.jocn.2023.12.021_b0165
  article-title: Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(22)00526-9
– volume: 10
  start-page: 89
  year: 2021
  ident: 10.1016/j.jocn.2023.12.021_b0150
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: Syst Rev
  doi: 10.1186/s13643-021-01626-4
– volume: 50
  start-page: 3299
  year: 2019
  ident: 10.1016/j.jocn.2023.12.021_b0310
  article-title: Stem cells as an emerging paradigm in stroke 4
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.119.025436
– volume: 336
  year: 2021
  ident: 10.1016/j.jocn.2023.12.021_b0025
  article-title: Neuroinflammation evoked by brain injury in a rat model of lacunar infarct
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2020.113531
– volume: 31
  start-page: 1263
  year: 2011
  ident: 10.1016/j.jocn.2023.12.021_b0330
  article-title: Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/jcbfm.2010.213
– volume: 39
  start-page: 899
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0145
  article-title: Randomized assessment of the safety and efficacy of intra-arterial infusion of autologous stem cells in subacute ischemic stroke
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A5586
– volume: 14
  start-page: 43
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0160
  article-title: SYRCLE’s risk of bias tool for animal studies
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-14-43
– volume: 1522
  start-page: 1
  year: 2013
  ident: 10.1016/j.jocn.2023.12.021_b0275
  article-title: Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2013.05.024
– volume: 22
  start-page: 977
  year: 2013
  ident: 10.1016/j.jocn.2023.12.021_b0110
  article-title: Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice
  publication-title: Cell Transplant
  doi: 10.3727/096368912X657251
– volume: 108
  start-page: 7838
  year: 2011
  ident: 10.1016/j.jocn.2023.12.021_b0335
  article-title: Direct reprogramming of mouse fibroblasts to neural progenitors
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1103113108
– volume: 176
  start-page: 69
  year: 2016
  ident: 10.1016/j.jocn.2023.12.021_b0215
  article-title: Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2016.04.003
– volume: 123
  start-page: 74
  year: 2019
  ident: 10.1016/j.jocn.2023.12.021_b0195
  article-title: Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke
  publication-title: Microvasc Res
  doi: 10.1016/j.mvr.2019.01.001
– volume: 8
  start-page: 102067
  year: 2017
  ident: 10.1016/j.jocn.2023.12.021_b0210
  article-title: Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.22155
– volume: 95
  start-page: 22
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0260
  article-title: Effect of repeated allogeneic bone marrow mononuclear cell transplantation on brain injury following transient focal cerebral ischemia in rats
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2013.12.016
– volume: 108
  start-page: 1005
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0090
  article-title: Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.09.084
– volume: 48
  year: 2021
  ident: 10.1016/j.jocn.2023.12.021_b0030
  article-title: Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2021.102197
– volume: 17
  start-page: 392
  year: 2015
  ident: 10.1016/j.jocn.2023.12.021_b0325
  article-title: Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2014.12.004
– volume: 201
  start-page: 668
  year: 2015
  ident: 10.1016/j.jocn.2023.12.021_b0230
  article-title: Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2015.03.137
– volume: 3
  start-page: 1322
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0245
  article-title: Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2013-0178
– volume: 20
  start-page: 101
  year: 2005
  ident: 10.1016/j.jocn.2023.12.021_b0125
  article-title: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study
  publication-title: Cerebrovasc Dis
  doi: 10.1159/000086518
– volume: 31
  year: 2022
  ident: 10.1016/j.jocn.2023.12.021_b0290
  article-title: Dental pulp stem cell therapy in ischemic stroke: A meta-analysis of preclinical studies
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2022.106453
– volume: 12
  year: 2020
  ident: 10.1016/j.jocn.2023.12.021_b0080
  article-title: Revisiting stem cell-based clinical trials for ischemic stroke
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2020.575990
– volume: 359
  start-page: 1317
  year: 2008
  ident: 10.1016/j.jocn.2023.12.021_b0055
  article-title: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0804656
– volume: 105
  start-page: 829
  year: 2001
  ident: 10.1016/j.jocn.2023.12.021_b0070
  article-title: The evolving concept of a stem cell: entity or function?
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00409-3
– volume: 5
  start-page: e1386
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0250
  article-title: Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2014.359
– volume: 6
  start-page: 11
  year: 2015
  ident: 10.1016/j.jocn.2023.12.021_b0320
  article-title: The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt544
– ident: 10.1016/j.jocn.2023.12.021_b0100
  doi: 10.1016/j.pneurobio.2018.05.004
– volume: 7
  start-page: 10523
  year: 2016
  ident: 10.1016/j.jocn.2023.12.021_b0040
  article-title: Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury
  publication-title: Nat Commun
  doi: 10.1038/ncomms10523
– volume: 36
  start-page: 10529
  year: 2016
  ident: 10.1016/j.jocn.2023.12.021_b0075
  article-title: Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1643-16.2016
– volume: 18
  start-page: 683
  year: 2009
  ident: 10.1016/j.jocn.2023.12.021_b0135
  article-title: Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2008.0253
– volume: 1680
  start-page: 143
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0140
  article-title: Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2017.12.017
– volume: 22
  start-page: 7703
  year: 2021
  ident: 10.1016/j.jocn.2023.12.021_b0020
  article-title: Neural stem cells for early ischemic stroke
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22147703
– volume: 6
  start-page: 74
  year: 2018
  ident: 10.1016/j.jocn.2023.12.021_b0105
  article-title: Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study
  publication-title: J Neurorestoratology
  doi: 10.26599/JNR.2018.9040002
– volume: 109
  start-page: 2527
  year: 2012
  ident: 10.1016/j.jocn.2023.12.021_b0340
  article-title: Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1121003109
– volume: 126
  start-page: 1302
  year: 2013
  ident: 10.1016/j.jocn.2023.12.021_b0280
  article-title: Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke
  publication-title: Chin Med J (Engl)
  doi: 10.3760/cma.j.issn.0366-6999.20122965
– volume: 96
  start-page: e1012
  year: 2021
  ident: 10.1016/j.jocn.2023.12.021_b0170
  article-title: STARTING-2 Collaborators. Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000011440
– ident: 10.1016/j.jocn.2023.12.021_b0180
  doi: 10.1172/jci.insight.126268
– volume: 21
  start-page: 1033
  year: 2019
  ident: 10.1016/j.jocn.2023.12.021_b0200
  article-title: Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2019.04.055
– volume: 45
  start-page: 634
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0060
  article-title: Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.113.003379
– volume: 4
  start-page: 841
  year: 2015
  ident: 10.1016/j.jocn.2023.12.021_b0095
  article-title: Bystander effect fuels human induced pluripotent stem cell-derived neural stem cells to quickly attenuate early stage neurological deficits after stroke
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2014-0184
– volume: 71
  start-page: 226
  year: 2020
  ident: 10.1016/j.jocn.2023.12.021_b0185
  article-title: Topically applied adipose-derived mesenchymal stem cell treatment in experimental focal cerebral ischemia
  publication-title: J Clin Neurosci
  doi: 10.1016/j.jocn.2019.08.051
– volume: 174
  start-page: 11
  year: 2002
  ident: 10.1016/j.jocn.2023.12.021_b0345
  article-title: Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats
  publication-title: Exp Neurol
  doi: 10.1006/exnr.2001.7853
– volume: 5
  start-page: 129
  year: 2014
  ident: 10.1016/j.jocn.2023.12.021_b0255
  article-title: Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt519
– volume: 301
  start-page: 287
  year: 2016
  ident: 10.1016/j.jocn.2023.12.021_b0220
  article-title: Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2015.07.048
– volume: 41
  start-page: 2064
  year: 2010
  ident: 10.1016/j.jocn.2023.12.021_b0130
  article-title: Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.109.575993
SSID ssj0009430
Score 2.37778
SecondaryResourceType review_article
Snippet •3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell...
Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 64
SubjectTerms Animals
Humans
Ischemic Stroke - therapy
Neural Stem Cells - transplantation
Stem Cell Transplantation - methods
Title Opportunities for developing neural stem cell treatments for acute ischemic stroke: A systematic review and gap analysis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0967586823004009
https://dx.doi.org/10.1016/j.jocn.2023.12.021
https://www.ncbi.nlm.nih.gov/pubmed/38199150
https://www.proquest.com/docview/2913449809
Volume 120
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1532-2653
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009430
  issn: 0967-5868
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1532-2653
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009430
  issn: 0967-5868
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1532-2653
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009430
  issn: 0967-5868
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1532-2653
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009430
  issn: 0967-5868
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1532-2653
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009430
  issn: 0967-5868
  databaseCode: AKRWK
  dateStart: 19940101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA6iIF7E385fRPAmdW2atI23IY6pqAcVdgtpmsgmdGNu4Mm_3feadsODCp5KSx4tea8vX5L3fSHkLIltxJw2QZanSMlxLshhnA04MzIOdSJkhuTk-4ek98Jv-6K_RK4aLgyWVda53-f0KlvXT9p1b7bHg0H7CcA3gN0Ed4owEpHEh-pfENMXn4syD5QXr_T2ICFg65o442u8hiODGqgsrpYEWfTT4PQT-KwGoe4GWa_RI-34D9wkS7bcIqv39f74Nvl4HCOenpWVTioFQEoXrCiK2pVgjdLNFBfs6bzK3DfVZja1dADzXayYh3aT0Zu9pB26kHumnupCdVnQVz2Gq9c02SEv3evnq15Qn60QmFhk08CIhKcuT22RyQhPqOIuFY6xwkUm1y6UzmhmhUtTYTXnqWFhlocpC_PIFoxF8S5ZLkel3SdUA6ZhBcxbALxwYZM8llrELBOFk64IixY5bzpVjb2Ehmpqy4YKXaDQBSpiClzQInHT76ohh0I6U5Dhf7USc6tv4fOn3WnjWgX_Ffa9Lu1o9q4YliRwmYWyRfa8z-dfj7NcCUj64J9vPSRrcMd98fcRWZ5OZvYYsM00P6mC94SsdG7ueg9fIFz5Fg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED66BLa-lK3dunS_NOjbMLFlybb2FspKsjbpw1rom5BlqSQDJ7QJ9M_vnWUn7KEb7Mlg67C5k0-fpPs-AZxmqUu4NzYqypwoOd5HJY6zkeBWpbHJpCqInDydZeMb8fNW3u7BWceFobLKNveHnN5k6_bOsPXmcDWfD38h-Eawm9FOEfVE9QL6QmJO7kF_NLkYz3bau6I5coTaR2TQcmdCmddiaUkGlafNqiBPnhufnsOfzTh0_hoOWgDJRuEb38Ceqw_h5bTdIj-Cx6sVQepN3UilMsSkbEeMYiRfidak3sxozZ5tC81DU2M3a8fmOOWlonlsd7_87b6zEdspPrPAdmGmrtidWeE1yJq8hZvzH9dn46g9XiGyqSzWkZWZyH2Zu6pQCR1SJXwuPeeVT2xpfKy8NdxJn-fSGSFyy-OijHMel4mrOE_Sd9Crl7V7D8wgrOEVTl0QvwjpsjJVRqa8kJVXvoqrAXzrnKpXQUVDd-VlC00h0BQCnXCNIRhA2vldd_xQzGgak_xfreTW6o8e9E-7r11oNf5a5HtTu-XmQXOqShCqiNUAjkPMt19PE12FYPrkP9_6BV6Nr6eX-nIyu_gA-_hEhFrwj9Bb32_cJ4Q66_Jz25WfAJWZ-8E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opportunities+for+developing+neural+stem+cell+treatments+for+acute+ischemic+stroke%3A+A+systematic+review+and+gap+analysis&rft.jtitle=Journal+of+clinical+neuroscience&rft.au=Buchlak%2C+Quinlan+D&rft.au=Esmaili%2C+Nazanin&rft.au=Moore%2C+Justin&rft.date=2024-02-01&rft.pub=Elsevier+Ltd&rft.issn=0967-5868&rft.volume=120&rft.spage=64&rft.epage=75&rft_id=info:doi/10.1016%2Fj.jocn.2023.12.021&rft.externalDocID=S0967586823004009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0967-5868&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0967-5868&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0967-5868&client=summon